Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
13.50
+0.14 (1.05%)
At close: Mar 18, 2026, 4:00 PM EDT
13.56
+0.06 (0.44%)
After-hours: Mar 18, 2026, 7:35 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $4.2 billion as of March 18, 2026. Its market cap has increased by 1,024.27% in one year.
Market Cap
4.20B
Enterprise Value
3.90B
1-Year Change
1,024.27%
Ranking
Category
Stock Price
$13.50
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $4.20B, an increase of 125.79%. That is a compound annual growth rate of 19.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 4.20B | 297.55% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TG Therapeutics | 4.80B |
| Apogee Therapeutics | 4.64B |
| CRISPR Therapeutics AG | 4.58B |
| Scholar Rock Holding | 4.57B |
| Amicus Therapeutics | 4.51B |
| Terns Pharmaceuticals | 4.30B |
| Ligand Pharmaceuticals | 4.18B |
| Viking Therapeutics | 3.88B |